Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T18:50:37.729Z.
Calculation as of: 2026-10-06T18:50:37.729Z.
Quote observation: 2026-10-06T18:30:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d0d3cab615a00e4182867faf392a700f3c2ff11ca91232cb78ad2c83a49f3690
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Bone Biologics Corporation
Market Cap
$843637.00
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$849293.00
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$893920.00
EV/EBIT Ratio
N/A
TTM Avg
1487.85x
3Y Avg
7742.21x
5Y Avg
7742.21x
Market Cap
$742225.00
EV/EBIT Ratio
N/A
TTM Avg
4890412.78x
3Y Avg
4039256.57x
5Y Avg
4039256.57x
Market Cap
$1.02M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$663982.00
EV/EBIT Ratio
5.81x
TTM Avg
18.06x
3Y Avg
18.06x
5Y Avg
18.06x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bone Biologics Corporation (BBLG) | $843637.00 | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $840882.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $834466.00 | N/A | 6.10x | 6.10x | 6.10x |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $849293.00 | N/A | N/A | N/A | N/A |
| Sunshine Biopharma, Inc. (SBFM)vs › | $880215.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A | 1487.85x | 7742.21x | 7742.21x |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $742225.00 | N/A | 4890412.78x | 4039256.57x | 4039256.57x |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $663982.00 | 5.81x | 18.06x | 18.06x | 18.06x |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
